Bioness announced it has received a medical device license from Health Canada for its StimRouter Neuromodulation System for the treatment of chronic peripheral nerve pain (excluding the cranial facial region). The Canadian medical device license provides approval to commercialize StimRouter and begin sales throughout Canada. Building upon the StimRouter’s successful launch in the United States and Europe, this Health Canada …

Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) (“Sirtex”), an Australia-based global life sciences company focused on interventional oncology therapies, that is listed on the Australian Securities Exchange, for A$28 per share in cash. On a fully diluted basis, this represents a total equity purchase price for …

Caresyntax® Inc. announced that Miami-based Med-Lab Supply, which focuses on the sales, installation and service of diagnostic imaging systems, will act as the exclusive salesforce and distributor of caresyntax’s surgical performance management software in South Florida. Med-Lab announced that its first installation of caresyntax technology is underway at Delray Medical Center, a 493-bed acute care hospital and a Level I …

GE Healthcare unveiled a new ultrasound system with impeccable image quality and advanced yet easy-to-use features.  From obstetrics and gynecology to general practitioners and family practice physicians, Versana Essential1 offers an imaging system that enables clinicians to confidently deliver the next level of care to their patients. At an affordable cost, this ultrasound system helps to meet realities on the …

Boston Scientific Corporation announced it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation (MR). Under the terms of the agreements, Boston Scientific has purchased a portion of the outstanding shares of Millipede along with newly …

Siemens Healthineers and Florida Hospital have announced a multi-phase collaboration agreement to transform health care delivery through the development of outcomes-based collaborative projects. The long-term agreement leverages the imaging technology innovation and industry expertise of Siemens Healthineers as well as the integrated delivery network (IDN) of Florida Hospital and its ongoing investment in improving health care affordability, outcomes, and experience …

Centric Medical announced the FDA 510(k) clearance of the new Foot and Ankle Plating System. This clearance offers multiple surgical solutions by Centric Medical, to be used in Foot & Ankle reconstruction procedures. The Centric Medical Foot and Ankle Plating System is comprised of a variety of plates and screws intended to stabilize and fixate bone for a myriad of …

Bovie Medical Corporation announced that it has enrolled the first patient in a U.S. Investigational Device Exemption (IDE) clinical study of its J-Plasma technology for use in dermal skin resurfacing. The clinical study is a multi-center, single arm, evaluator-blind prospective study evaluating the safety and efficacy of Bovie Medical’s J-Plasma technology for the reduction of facial wrinkles and rhytides. The …

Cellular Biomedicine Group Inc., a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory platform, which will be designed to speed up manufacturing timelines for its cell therapy clinical trials and commercial launch. There are more than 900 regenerative medicine trials …

Inform Diagnostics announced that therapeutic drug monitoring is commercially available for Renflexis (infliximab-abda), a biosimilar of Remicade (infliximab). Since launching the InformTx therapeutic drug monitoring (TDM) services in June 2016, the company has expanded its TDM testing to now eight biologic drugs that treat inflammatory bowel disease (IBD). Inform Diagnostics uses laboratory-validated ELISA technology for TDM. Testing measures the level …